AFP and hepatocellular carcinoma: First, all of the patients enrolled in our study, including those without underlying advanced fibrosis or cirrhosis, underwent a routine biannual HCC surveillance based upon abdominal ultrasonography and serum alpha-fetoprotein during antiviral treatment and the follow-up after SVR.